Tropical Journal of Pharmaceutical Research

Original Research Article | OPEN ACCESS

Luteolin attenuates high glucose-induced cytotoxicity by suppressing TXNIP expression in neuronal cells

Tuerhong Tuerxun , Xiaopeng Li, Long Ma, Yi Wang, Bo Liu, Xiangyou Yu

Department of Intensive Care Unit, The First Affiliated Hospital of Xinjiang Medical University, Xinjiang 830054, China;

For correspondence:- Tuerhong Tuerxun Email: TuerhongTuerxunsdr@163.com Tel:+869914319317

Accepted: 24 October 2019 Published: 30 November 2019

Citation: Tuerxun T, Li X, Ma L, Wang Y, Liu B, Yu X. Luteolin attenuates high glucose-induced cytotoxicity by suppressing TXNIP expression in neuronal cells. Trop J Pharm Res 2019; 18(11):2271-2277 doi: 10.4314/tjpr.v18i11.6

© 2019 The authors.
This is an Open Access article that uses a funding model which does not charge readers or their institutions for access and distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0) and the Budapest Open Access Initiative (http://www.budapestopenaccessinitiative.org/read), which permit unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited..

Abstract

Purpose: To determine the potential effect of luteolin in neuroprotection using an in vitro model of diabetic neuropathy (DN) in PC12 cells by high glucose (HG)-induced neurotoxicity.

Methods: PC12 cells were pretreated with HG media for 3, 6, 12, and 24 h, followed by treatment with increasing concentrations of luteolin (10, 25, and 50 ug/ml) for 24 hours. Following luteolin treatment, the cells were transfected with a plasmid expressing thioredoxin-interacting protein (TXNIP). To evaluate HG-induced cytotoxicity, the expression levels of the inflammatory markers interleukin (IL)-8, IL-6, and tumor necrosis factor-α (TNF-α) were evaluated by quantitative reverse transcription PCR (qRT-PCR) and ELISA. In addition, the apoptotic cells were assessed by flow cytometry. The expression levels of TXNIP protein and mRNA were determined by western blotting and qRT-PCR, respectively.

Results: Luteolin decreased the expression levels of TNF-α, IL-1β, and IL-6 in a dose-dependent manner at both the protein and mRNA level. Luteolin also decreased HG-induced apoptosis in PC12 cells (p < 0.05). The expression of B-cell lymphoma 2 (BCL-2) was suppressed, whereas those of cleaved PARP and cleaved caspase-3 were increased following HG treatment. Luteolin treatment had the opposite effect in a dose-dependent manner (p < 0.05). Luteolin reduced HG-induced inflammation and apoptosis in PC12 cells by inhibiting TXNIP expression (p < 0.05).

Conclusion: These data indicate that the neuroprotective effects of luteolin is probably exerted its anti-apoptotic and anti-inflammatory activities via the TXNIP pathway.

Keywords: Luteolin, Diabetic neuropathy, High glucose, PC12 cells, Inflammation, Apoptosis